Nipt denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for nipt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied NIPT as Non-Formulary

A non-formulary denial for a laboratory test like non-invasive prenatal testing (NIPT) is unusual but does occur in certain UHC plan designs where genetic tests are managed under a laboratory benefit or require use of a contracted or preferred laboratory. If the ordering provider sent the specimen to a laboratory not in UHC's preferred network, or if the specific NIPT product is not on UHC's designated-lab list, the claim may be denied as non-formulary or out-of-network rather than on clinical grounds.

This denial type is often addressable through a combination of a network/formulary exception request and, if the clinical indication is sound, a concurrent medical-necessity appeal. The two tracks can and should run simultaneously.

## Federal Appeal Framework

• ACA §2719 external review: for fully insured non-grandfathered plans, independent external review is available after you exhaust internal appeals. Your denial letter will state the external-review deadline — typically around four months from the final internal denial.
• ERISA §503: self-funded plans are governed by their plan documents after internal exhaustion.
• Non-formulary / exception process: separately from the clinical appeal, most plans have a formal formulary exception or network exception pathway. Ask UHC's member services specifically about the laboratory benefit exception process for your plan.

## Appeal Process and Timeline

1. Confirm with UHC member services whether the denial is laboratory-network, formulary (lab product), or plan-benefit based — the remedy differs for each. 2. Identify UHC's preferred or contracted NIPT laboratory for your plan; confirm whether the ordering provider could have directed the order there. 3. File a Level 1 internal appeal addressing both the formulary/network basis and the clinical necessity of the test simultaneously. 4. If the denial was purely administrative (wrong lab), escalation is often faster than a full clinical appeal.

## Documentation to Gather

• Lab-selection documentation: the ordering provider's reason for selecting the specific laboratory used, and any documentation that a preferred lab was not available, accessible, or clinically equivalent for this patient.
• Clinical indication documentation: even in a non-formulary appeal, include the clinical indication supporting NIPT so the appeal record is complete.
• Ordering provider letter: addresses both the lab-selection rationale and the clinical necessity of the test.
• Plan benefit document: pull the laboratory benefit section of your Summary Plan Description to understand whether an out-of-network or non-preferred lab exception is available.

## Criteria-Mapping Structure

For this appeal, the criteria table has two sections: (1) the formulary/network exception criteria from the plan document — map each to a documented reason why the non-preferred lab was used; and (2) the clinical coverage criteria from the UHC NIPT policy — map each to the relevant chart fact. Addressing only the formulary track without the clinical track (or vice versa) leaves the other ground open for a secondary denial.